CTOs on the Move

Reata Pharmaceuticals

www.reatapharma.com

 
Reata Pharmaceuticals is the leader in discovering and developing novel, oral anti-inflammatory drugs that activate Nrf2, the primary regulator of cellular antioxidant and detoxification enzymes.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Penny Muir
Associate Director, Compliance Profile

Funding

Reata Pharmaceuticals raised $505M on 11/18/2019
Reata Pharmaceuticals raised $350M on 06/11/2020

Similar Companies

AMGIT

AMGIT is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corepharma LLC

Corepharma LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Dragon Pharmaceuticals

Dragon Pharmaceuticals Inc. (OTC-BB: Drug) is an international biotech company headquartered in Vancouver, Canada, with production and R&D facilities in Nanjing, China and 160 employees worldwide. The Company develops and commercializes human proteins for therapeutic use. Using superior and proprietary DNA vector technology, Dragon is able to produce high yields of quality protein drugs at low costs and high margins. Dragon is one of the world`s largest producers of Epoetin Alfa, or EPO, a therapeutic protein used to treat anemia related to kidney failure, chemotherapy, and surgery. Dragon`s EPO is approved and being marketed for use in chronic renal failure in China, Egypt, India and Peru. Additional regulatory submissions are in progress throughout Central and Eastern Europe, Southeast Asia, Latin America and the Middle East.

Ambrilia Biopharma

Ambrilia Biopharma Inc. is a Verdun, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.